[Japanese cedar pollinosis in infants in the allergy clinic]

S Masuda1, A Terada, T Fujisawa

  • 1Department of Otorhinolaryngology, National Mie Hospital.

Arerugi = [Allergy]
|February 24, 2001
PubMed

Insights

Japanese cedar pollinosis is increasing in children. This study found Japanese cedar pollen sensitization can occur in infants as young as 1 year 8 months, with pollinosis developing by age 2.

Area of Science:

  • Allergy and Immunology
  • Pediatric Medicine
  • Environmental Health

Context:

  • Japanese cedar (Cryptomeria japonica) pollinosis is a growing concern, particularly in children.
  • Limited data exists on the incidence and sensitization rates of Japanese cedar pollinosis in infants.
  • This study addresses the knowledge gap regarding early-life exposure and allergic responses to Japanese cedar pollen.

Purpose:

  • To investigate the rate of sensitization to Japanese cedar pollen in infants and young children (under 6 years old).
  • To determine the age of onset for Japanese cedar pollinosis in this pediatric population.
  • To identify common symptoms and co-sensitization patterns in affected infants.

Summary:

  • A study of 76 infants (2 months-5 years) visiting a pediatric allergy clinic found a 27.6% positive rate for Japanese cedar pollen sensitization (CAP-RAST).
  • The youngest child sensitized was 1 year 8 months old; the youngest diagnosed with pollinosis was 2 years 5 months old.
  • Symptoms included rhinorrhea, eye irritation, cough, and snoring, with many also sensitized to house dust mites.

Impact:

  • Japanese cedar pollen sensitization can occur after approximately two seasons of exposure.
  • Japanese cedar pollinosis is a potential health issue for infants, not just older children.
  • Findings highlight the need for early detection and management strategies for Japanese cedar pollinosis in young children.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...